Research and Markets Biotechnology and Pharmaceutical Companies Looking to Incorporate Genomics Technologies into their Corporate Strategies



May 6, 2005 -- Research and Markets (http://www.researchandmarkets.com/reports/c16914) has announced the addition of Genomics World Markets to their offering.

The report develops forecasts for genomics-based products, services, and applications from 2000 through 2005. The report also focuses on the efforts of biotechnology companies and pharmaceutical firms to incorporate genomics technologies into their corporate strategies.

Individual market chapters cover revenues and forecasts for each individual product segment relevant to the report . A section covering the competitive positions of leading participants is also included, with estimated market share standings and brief descriptions of companies with important products and/or innovations likely to favorably affect future sales levels.

The scope of the study is worldwide. The overview section provides extended definitions of the components of genomics to provide the reader with a clear understanding of the technology involved. In addition, this section provides an analysis of how genomics will transform the health-care industry and discusses agricultural and other non-medical applications of genomics.

The industry structure section provides an overview of the structure of the genomics industry and the patents that apply to genomics, and discusses the reaction on Wall Street to the genomics revolution. The company profiles section includes a detailed discussion of the companies that have pioneered the genomics revolution and examines how their available products and services are transforming the practice of medicine.

Companies Mentioned:
Aclara Biosciences
Affymetrix
AlphaGene, Inc.
Aligent Technologies
Amersham Pharmacia Biotech
Applied Biosystems
Aurora Biosciences
AXYS Pharmaceuticals, Inc.
Bayer, AG
Celera Genomics
Clinical Micro Sensors
CuraGen Corporation
Diversa
Gene Logic
Genometrix
Hyseq
Illumina
Incyte Pharmaceuticals
Gene Machines
Luminex Corporation
Paradigm Genetics (Icoria)
Orchid Biosciences
Protogene
Rosetta Inpharmatics
Sequenom
HiberGen
Research Genetics
Caliper technologies
Genentech, Inc.
Genomic Solutions (Harvard Biosceiences)
Genset
Human Genome Sciences, Inc.
Lynx Therapeutics, Inc.
Millennium Pharmaceuticals, Inc.
Myriad Genetics, Inc.
Nanogen, Inc.
PE Lifesciences
Aber Genomic Computing
DeCode Genetics
Spotfire, Inc.
454 Life Sciences

For more information visit http://www.researchandmarkets.com/reports/c16914

Laura Wood
Senior Manager
Research and Markets
e-mail protected from spam bots
Fax: +353 1 4100 980





Research and Markets Biotechnology and Pharmaceutical Companies Looking to Incorporate Genomics Technologies into their Corporate Strategies